Potassium Carbonate → HCID 86652738, compound
Reaction equation
Cl.[CH3:2][N:3]1[CH2:8][CH2:7][N:6]([S:9](Cl)(=[O:11])=[O:10])[CH2:5][CH2:4]1.Cl.[F:14][C:15]1[CH:20]=[CH:19][C:18]([NH:21][C:22]([NH:24][O:25][CH:26]2[CH2:31][CH2:30][NH:29][CH2:28][CH2:27]2)=[O:23])=[CH:17][CH:16]=1.C([O-])([O-])=O.[K+].[K+]>O.O1CCOCC1>[F:14][C:15]1[CH:20]=[CH:19][C:18]([NH:21][C:22]([NH:24][O:25][CH:26]2[CH2:31][CH2:30][N:29]([S:9]([N:6]3[CH2:7][CH2:8][N:3]([CH3:2])[CH2:4][CH2:5]3)(=[O:11])=[O:10])[CH2:28][CH2:27]2)=[O:23])=[CH:17][CH:16]=1Participants
Procedure
4-Methylpiperazine-1-sulfonyl chloride hydrochloride (227 mg, 0.966 mmol) was added at room temperature to a solution of 1-(4-fluorophenyl)-3-(piperidin-4-yloxy)urea hydrochloride (140 mg, 0.483 mmol) and K2CO3 (200 mg, 1.45 mmol) in H2O-dioxane (1:1, 4 ml), and the whole was stirred at room temperature for 18 hours. The reaction was quenched with K2CO3 (200 mg) in H2O (10 ml), extracted with ethyl acetate (20 ml×3). The combined organic layer was washed with brine (10 ml), dried over Na2SO4, filtered and concentrated in vacuo. The residue was purified by column chromatography (chloroform/methanol: 90/10) to give 1-(4-fluorophenyl)-3-(1-(4-methylpiperazin-1-ylsulfonyl)piperidin-4-yloxy)urea (139 mg, 69%) as pale yellow amorphous: LCMS: 416 [M+1]+. 1H NMR (DMSO-d6) δ: 1.72 (m, 2H), 1.93 (m, 2H), 2.19 (s, 3H), 2.35 (m, 4H), 3.01-3.13 (m, 6H), 3.45 (m, 2H), 3.85 (m, 1H), 7.11 (m, 2H), 7.55 (m, 2H), 8.68 (s, 1H), 9.45 (s, 1H).
Workup
- customThe reaction was quenched with K2CO3 (200 mg) in H2O (10 ml)
- extractionextracted with ethyl acetate (20 ml×3)
- washThe combined organic layer was washed with brine (10 ml)
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationconcentrated in vacuo
- customThe residue was purified by column chromatography (chloroform/methanol: 90/10)
Sources & evidence
- ORD record
- ord-5b8b504af56c4d7cbd2099455d3b1cd1
- Source dataset
- uspto-grants-2013_08
- Patent number
- US08518934B2
Reaction notes
Loading…